Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Neoplasm Metastasis 11Carcinoma, Hepatocellular 7Colorectal Neoplasms 6Liver Neoplasms 5Rectal Neoplasms 4Colonic Neoplasms 4Pancreatic Neoplasms 3Lung Neoplasms 3Kidney Neoplasms 3Breast Neoplasms 3Pain 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Thymoma 1Small Cell Lung Carcinoma 1Sarcoma 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms 1Multiple Advanced Tumors After PD-1 Therapy Failure 1Mesothelioma, Malignant 1Jaundice, Obstructive 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Cancer Liver Metastases 1Biliary Tract Neoplasms 1Bile Duct Neoplasms 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

Sunitinib 5pembrolizumab 4Paclitaxel 4Carboplatin 4Radiotherapy 3Cyclophosphamide 3Cisplatin 3selinexor 2lenvatinib 2Taxes 2Ramucirumab 2Octreotide 2N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 2Methylprednisolone 2Erlotinib Hydrochloride 2Chemoradiotherapy 2zimberelimab 1saracatinib 1regorafenib 1epacadostat 1envafolimab 1belinostat 1avelumab 1atezolizumab 1amrubicin 1alovudine 1TP protocol 1Radiofrequency Ablation 1Radiation Dose Hypofractionation 1Prednisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Thymoma × Radiofrequency Ablation × Clear all
NCT00024076 2020-08-03

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

Jonsson Comprehensive Cancer Center

Phase 2 Completed
30 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Thymoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡